Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Europe Drug Delivery Devices Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value & Volume
5.2. Market Share & Forecast
5.2.1. By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery and Others)
5.2.2. By Device (Syringes, Inhalers, Patch Pumps, And Others)
5.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
5.2.4. By Country
5.2.5. By Company (2022)
5.3. Market Map
5.3.1. By Route of Administration
5.3.2. By Device
5.3.3. By End User
5.3.4. By Country
5.4. Europe: Country Analysis
5.4.1. France Drug Delivery Devices Market Outlook
5.4.1.1. Market Size & Forecast
5.4.1.1.1. By Value
5.4.1.2. Market Share & Forecast
5.4.1.2.1. By Route of Administration
5.4.1.2.2. By Device
5.4.1.2.3. By End User
5.4.2. Germany Drug Delivery Devices Market Outlook
5.4.2.1. Market Size & Forecast
5.4.2.1.1. By Value
5.4.2.2. Market Share & Forecast
5.4.2.2.1. By Route of Administration
5.4.2.2.2. By Device
5.4.2.2.3. By End User
5.4.3. United Kingdom Drug Delivery Devices Market Outlook
5.4.3.1. Market Size & Forecast
5.4.3.1.1. By Value
5.4.3.2. Market Share & Forecast
5.4.3.2.1. By Route of Administration
5.4.3.2.2. By Device
5.4.3.2.3. By End User
5.4.4. Italy Drug Delivery Devices Market Outlook
5.4.4.1. Market Size & Forecast
5.4.4.1.1. By Value
5.4.4.2. Market Share & Forecast
5.4.4.2.1. By Route of Administration
5.4.4.2.2. By Device
5.4.4.2.3. By End User
5.4.5. Spain Drug Delivery Devices Market Outlook
5.4.5.1. Market Size & Forecast
5.4.5.1.1. By Value
5.4.5.2. Market Share & Forecast
5.4.5.2.1. By Route of Administration
5.4.5.2.2. By Device
5.4.5.2.3. By End User
5.4.6. Switzerland Drug Delivery Devices Market Outlook
5.4.6.1. Market Size & Forecast
5.4.6.1.1. By Value
5.4.6.2. Market Share & Forecast
5.4.6.2.1. By Route of Administration
5.4.6.2.2. By Device
5.4.6.2.3. By End User
5.4.7. Netherlands Drug Delivery Devices Market Outlook
5.4.7.1. Market Size & Forecast
5.4.7.1.1. By Value
5.4.7.2. Market Share & Forecast
5.4.7.2.1. By Route of Administration
5.4.7.2.2. By Device
5.4.7.2.3. By End User
5.4.8. Russia Drug Delivery Devices Market Outlook
5.4.8.1. Market Size & Forecast
5.4.8.1.1. By Value
5.4.8.2. Market Share & Forecast
5.4.8.2.1. By Route of Administration
5.4.8.2.2. By Device
5.4.8.2.3. By End User
5.4.9. Sweden Drug Delivery Devices Market Outlook
5.4.9.1. Market Size & Forecast
5.4.9.1.1. By Value
5.4.9.2. Market Share & Forecast
5.4.9.2.1. By Route of Administration
5.4.9.2.2. By Device
5.4.9.2.3. By End User
5.4.10. Belgium Drug Delivery Devices Market Outlook
5.4.10.1. Market Size & Forecast
5.4.10.1.1. By Value
5.4.10.2. Market Share & Forecast
5.4.10.2.1. By Route of Administration
5.4.10.2.2. By Device
5.4.10.2.3. By End User
6. Market Dynamics
6.1. Drivers
6.2. Challenges
7. Market Trends & Developments
8. Competitive Landscape
8.1. F. Hoffmann-La Roche Ltd
8.2. Antares Pharma
8.3. Novartis AG
8.4. 3M Company
8.5. Sulzer Ltd
8.6. Gerresheimer AG
8.7. Sanofi S.A.
8.8. Johnson & Johnson Services, Inc.
8.9. Bayer AG
8.10. GlaxoSmithKline plc
9. Strategic Recommendations